|
显示项目 740796-740805 / 2348570 (共234857页)
<< < 74075 74076 74077 74078 74079 74080 74081 74082 74083 74084 > >>
每页显示[10|25|50]项目
| 嘉南藥理大學 |
2015-08 |
Safety and efficacy of manual syringe infusion of distending media for hysteroscopic procedures: a case-control study
|
Ting, Wan-Hua; Lin, Ho-Hsiung; Wu, Ming-Ping; Tu, Fung-Chao; Peng, Fu-Shiang; Hsiao, Sheng-Mou |
| 臺北醫學大學 |
2009 |
Safety and efficacy of mixing cetrorelix with follitropin alfa -a randomized study
|
曾啟瑞 |
| 臺北醫學大學 |
2009 |
Safety and efficacy of mixing cetrorelix with follitropin alfa: a randomized study
|
溫永銳; Lin YH; Wen YR; Chang Y; Seow KM; Hsieh BC; Hwang JL; Tzeng CR |
| 中國醫藥大學 |
2010-06 |
Safety and efficacy of mixing cetrorelix with follitropin alfa: a randomized study
|
林禹宏(Yu-Hung Lin); 溫永銳(Yeong-Ray Wen); (Yuanmay Chang); 蕭國明(Kok-Min Seow); 謝碧純(Bih-Chwen Hsieh); 黃建榮(Jiann-Loung Hwang)*; (Chii-Ruey Tzeng) |
| 臺大學術典藏 |
2021-04-23T05:56:29Z |
Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 study
|
Tan D.S.-W.;Leighl N.B.;Riely G.J.;Chih-Hsin Yang;Sequist L.V.;Wolf J.;Seto T.;Felip E.;Aix S.P.;Jonnaert M.;Pan C.;Tan E.Y.;Ko J.;Moody S.E.;Kim D.-W.; Tan D.S.-W.; Leighl N.B.; Riely G.J.; CHIH-HSIN YANG; Sequist L.V.; Wolf J.; Seto T.; Felip E.; Aix S.P.; Jonnaert M.; Pan C.; Tan E.Y.; Ko J.; Moody S.E.; Kim D.-W. |
| 國家衛生研究院 |
2018-12-19 |
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: Interim results of a randomized, phase 2 trial (AT
|
Boku, N;Ryu, MH;Kato, K;Chung, HC;Minashi, K;Lee, KW;Cho, H;Kang, WK;Komatsu, Y;Tsuda, M;Yamaguchi, K;Hara, H;Fumita, S;Azuma, M;Chen, LT;Kang, YK |
| 國立成功大學 |
2019 |
Safety and efficacy of nivolumab in combination with s-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: Interim results of a randomized, phase II trial (a
|
Boku, N.;Ryu, M.-H.;Kato, Kato K.;Chung, H.C.;Minashi, K.;Lee, K.-W.;Cho, H.;Kang, W.K.;Komatsu, Y.;Tsuda, M.;Yamaguchi, K.;Hara, Hara H.;Fumita, S.;Azuma, M.;Chen, L.-T.;Kang, Y.-K. |
| 臺大學術典藏 |
2021-02-02T02:47:58Z |
Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study
|
Yu K.-H.; Lai J.-H.; PING-NING HSU; Chen D.-Y.; Chen C.-J.; Lin H.-Y. |
| 臺大學術典藏 |
2022-03-10T02:31:38Z |
Safety and efficacy of pegylated liposomal doxorubicinbased adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer
|
Lien M.-Y.; Liu L.-C.; Wang H.-C.; Yeh M.-H.; Chen C.-J.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Li L.-Y.; PO-HAN LIN; Chiu C.-F. |
| 臺大學術典藏 |
2021-01-05T06:41:07Z |
Safety and efficacy of pregabalin in adolescents with fibromyalgia: A randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study
|
Arnold L.M.; Arnold L.M.;Schikler K.N.;Bateman L.;Khan T.;Pauer L.;Bhadra-Brown P.;Clair A.;Chew M.L.;Scavone J.;Alario A.;Babhulkar S.S.;Berenguer R.;Freeman P.;Gold J.;Goodman S.;Jarosova H.;Lee W.;Liss J.;Lvovich S.;Maiquez A.;Morcos N.;Nellikunja S.;Passo M.;Schanberg L.;Sharma V.P.;Spencer C.;Toth M.;Veeravalli S.C.M.;Wen-Chin Weng;On Behalf Of The Pregabalin Adolescent Fibromyalgia Study Group; Nellikunja S.; Morcos N.; Maiquez A.; Lvovich S.; Liss J.; Lee W.; Jarosova H.; Goodman S.; Gold J.; Schikler K.N.; Bateman L.; Khan T.; Pauer L.; Bhadra-Brown P.; Clair A.; Chew M.L.; Scavone J.; Alario A.; Babhulkar S.S.; Berenguer R.; Freeman P.; Passo M.; Schanberg L.; Sharma V.P.; Spencer C.; Toth M.; Veeravalli S.C.M.; WEN-CHIN WENG; on behalf of the Pregabalin Adolescent Fibromyalgia Study Group |
显示项目 740796-740805 / 2348570 (共234857页)
<< < 74075 74076 74077 74078 74079 74080 74081 74082 74083 74084 > >>
每页显示[10|25|50]项目
|
